Jobs / United States / Pfizer INC
Translational AI Engineer
Pfizer INC · 🇺🇸 United States - Massachusetts - Cambridge
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Pfizer INC paid sponsored hires in similar roles2 certified filings for “SENIOR VALIDATION ENGINEER” (Industrial Engineers) in WA: $96k–$117k, median $107k. Most were filed at wage level I (50%) — 1 lottery entry, ≈15% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Pfizer INC
The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Pfizer INC →
About the role
ROLE SUMMARY: The technical engineering counterpart to AIDE’s applied workflow roles, embedded within the Research Unit to convert promising AI workflow concepts into durable, evaluated, and supportable systems that accelerate translational science. This position is focused less on discovering use cases and more on the gap that appears once a prototype needs to scale in a scientific setting. The role translates recurring needs from computational biology, immunology, and clinical teams into fit-for-purpose AI systems, including generative AI, agentic workflows, predictive models, foundation models, retrieval-augmented systems, and fine-tuned model architectures. It also builds the data, evaluation, integration, and deployment layers beneath those systems, ensuring that internal AI tools do not remain fragile scripts or demos. The ideal candidate is a hands-on translational AI engineer who can move fluidly between scientific intent, model behavior, and production-quality infrastructure. They should be comfortable reading and hardening AI-assisted codebases, standing up ETL (Extract, Transform, and Load) and database foundations, implementing cloud deployment and CI/CD patterns, and building evaluation harnesses that expose scientific, clinical, and technical failure modes before tools move from alpha to beta. The distinguishing strength is translational engineering judgment: turning ambiguous scientific needs into reliable AI systems, tracing failures to their root cause, defining fit-for-purpose evaluation with scientific and clinical partners, and knowing when to build internally versus adopt a commercial AI tool. This is a role for someone who turns promising AI workflows into systems that scientific and clinical partners can trust, reuse, and improve. ROLE RESPONSIBILITIES: • Design and build fit-for-purpose AI/ML systems for recurring scientific and clinical workflows, including hybrid RAG when grounding and domain context are required. • Take AI-assisted prototypes built across AIDE and Systems Immunology, identify their technical and scientific failure modes, and rebuild parts that need engineering before scaling for wider use. • Stand up lean data platform and ETL underneath these systems, in partnership with Digital, so tools do not “rot” into one-off scripts. • Own promotion of internal AI tools from alpha to beta, define what “production-ready” means for a given tool, and build the evaluation harness that proves it. • Establish and document the SOPs that help others build rigorously from day one, instead of discovering the gap after a tool is already widely used. • Rigorously evaluate commercial AI/ML and GenAI tools and vendors against a build-vs-buy bar, covering capability, cost, security, scientific fit, and workflow readiness to support go/no-go purchasing decisions. • Run evaluation loops that measure system quality against workflow-specific scientific or clinical benchmarks, using input from computational biologists, immunologists, biologists, and clinicians to drive model selection and iteration. • Distill what is learned into hardened primitives, reference architectures, and benchmark harnesses that scale across AIDE’s other tools and deployments. • Apply the same rigor to AI that any scientific or translational method would receive: fit-for-purpose evaluation, grounded outputs, documentation, guardrails, disclosure of model limitations, and human oversight. • Stay current on translational AI methods and infrastructure, including generative AI, agentic systems, predictive modeling, biological foundation models, retrieval and fine-tuning methods, and fit-for-purpose evaluation practices as they evolve. • Contribute to a culture in AIDE where rigor is expected rather than exceptional, including calling